ReviewAntibiotics (Basel, Switzerland)2024

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant

Chienhsiu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.